- $596.03m
- $693.93m
- $526.52m
Core Laboratories NV reports results for the quarter ended in March - Earnings Summary
Brief: Core Lab Reports Qtrly Adjusted Earnings Per Share $0.15
Core Laboratories NV expected to post earnings of 13 cents a share - Earnings Preview
NYSE ORDER IMBALANCE 237356.0 SHARES ON BUY SIDE
U.S. RESEARCH ROUNDUP-Cactus, NRG Energy, Translate Bio
U.S. RESEARCH ROUNDUP- Cabot Oil & Gas, Jounce Therapeutics, Vail Resorts
U.S. RESEARCH ROUNDUP-Apellis Pharmaceuticals, Motorola Solutions, Whirlpool
Brief: Core Lab Reports Q4 GAAP EPS OF $0.31
Brief: Core Laboratories NV - Entered Into At-The-Market Equity Offering Program And Equity Distribution Agreement
U.S. RESEARCH ROUNDUP-Core Laboratories NV, Helix Energy Solutions Group, Umpqua Holdings
Brief: Core Laboratories NV Reports Q3 Revenue $105.4 Mln
Brief: Core Laboratories NV Files For Mixed Shelf Offering, Size Not Disclosed
U.S. RESEARCH ROUNDUP- Cabot, Eagle Bancorp, Xylem
U.S. RESEARCH ROUNDUP-Boston Beer Company, ServiceNow, Xerox Holdings
Brief: Core Lab Reports Second Quarter 2020 Results From Continuing Operations
U.S. RESEARCH ROUNDUP-Boeing, Fortune Brands Home & Security, Fortune Brands Home & Security
Brief: Core Laboratories NV Announces Amendment To Revolving Credit Facility
Brief: Core Laboratories NV Says Amended Credit Facility Dated As Of June 19, 2018
NYSE ORDER IMBALANCE 306223.0 SHARES ON BUY SIDE